• No results found

Targeted therapies in rheumatoid arthritis - Stellingen

N/A
N/A
Protected

Academic year: 2021

Share "Targeted therapies in rheumatoid arthritis - Stellingen"

Copied!
2
0
0

Bezig met laden.... (Bekijk nu de volledige tekst)

Hele tekst

(1)

UvA-DARE is a service provided by the library of the University of Amsterdam (https://dare.uva.nl)

UvA-DARE (Digital Academic Repository)

Targeted therapies in rheumatoid arthritis

Boumans, M.J.H.

Publication date

2012

Link to publication

Citation for published version (APA):

Boumans, M. J. H. (2012). Targeted therapies in rheumatoid arthritis.

General rights

It is not permitted to download or to forward/distribute the text or part of it without the consent of the author(s) and/or copyright holder(s), other than for strictly personal, individual use, unless the work is under an open content license (like Creative Commons).

Disclaimer/Complaints regulations

If you believe that digital publication of certain material infringes any of your rights or (privacy) interests, please let the Library know, stating your reasons. In case of a legitimate complaint, the Library will make the material inaccessible and/or remove it from the website. Please Ask the Library: https://uba.uva.nl/en/contact, or a letter to: Library of the University of Amsterdam, Secretariat, Singel 425, 1012 WP Amsterdam, The Netherlands. You will be contacted as soon as possible.

(2)

STELLINGEN

1. Als we al weten dat een medicijn werkt, is het nog steeds interessant om te weten hoe het dan precies werkt (dit proefschrift)

2. B cel depletie leidt tot remming van de osteoclastogenese (dit proefschrift) 3. Één infuus van 1000 mg is waarschijnlijk voldoende voor de herbehandeling van

reumatoïde artritis patiënten met rituximab (dit proefschrift)

4. Patiënten met reumatoïde artritis en een verhoogde type I interferon signatuur in hun bloed responderen over het algemeen minder goed op rituximab (dit proefschrift) 5. Osteopontine is geen goed target voor de behandeling van reumatoïde artritis (dit proefschrift) 6. Je eerste publicatie kan best een editorial zijn (dit proefschrift) 7. Het gedicht ‘Odi et amo’ van Catullus past goed bij het doen van wetenschappelijk onderzoek 8. Een zachte g is zeldzaam in het AMC (eigen waarneming) 9. Als neutrino’s inderdaad sneller gaan dan licht, hebben we op den duur geen biomarkers voor respons op therapie meer nodig 10. Geniet nooit met mate (Loesje)

Referenties

GERELATEERDE DOCUMENTEN

Topographic maps for LI (left) and HI (right), at Pz, for No-Go trials in the Go/No-Go task. Visual representation of one trial in the SSRT. a blue circle) on Go trials (75%

Stopping the “World’s Greatest Threat”: Canadian Policy and Rhetoric towards the Iranian Nuclear Program during Stephen Harper’s Conservative Government, 2006-2015.. by

I think joy, and like, you know, just taking care of yourself and the people around you is really important to this work because we’re in it for the long haul. we have to take care

German’s report, the Corporate Registration program plays a key role in GPEB’s regulatory framework, and is a principal mechanism through which GPEB maintains control over

Britton (1997) concluded that race and gender are contributing factors in stress and further identified the need for future researchers to explore how these intersections

These structural investigations into the mechanism for germ-line antibody recognition of carbohydrate antigens utilizing chlamydial-specific and anti-lipid A antibodies

Our structural analysis revealed that while the N- terminal region of TbFam50.360 adopted a three-helical structure similar to previously characterized trypanosome surface

I showed that data on the structural differences between the native and aggregated forms of the prion protein, obtained from multiple structural proteomics approaches